FDA Appropriators Discuss Ending The Food & Drug Administration

Splitting food authorities out of FDA suggested by Wyoming Republican Cynthia Lummis as the House Appropriations Agriculture/FDA subcommittee queries FDA Commissioner Margaret Hamburg on FY 2013 funding.

Food safety predominated at the first congressional review of the administration’s fiscal 2013 FDA budget proposal Feb. 29, prompting members of the House Appropriations Agriculture/FDA Subcommittee to revisit two issues that have failed to pass in previous Congresses – removal of food safety from the FDA agenda and food facility registration fees.

Republicans raised the issues as the panel questioned FDA Commissioner Margaret Hamburg about the $4.5 billion budget request, whose funding would include $583 million in new user fees that have...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Pink Sheet

Non-User Fee Dollars Increased In US FDA’s Updated FY 2026 Budget Request

 

The budget authority total, which is significantly higher than the amount floated in an April OMB draft document, suggests there may have been successful lobbying to increase FDA funding.

US ‘Most Favored Nation’ Pricing Could be Game Changer for Drug Access In Germany

 

In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.

ICH Targets RWE, Rare Diseases, Biosimilars, ATMPs In New Guideline Push

 
• By 

The International Council for Harmonisation has identified four new topics that can benefit from global regulatory alignment, with timelines for initiating work to be determined later.